FDMT•benzinga•
4D Molecular Therapeutics FY 2024 GAAP EPS $(2.98) Misses $(2.92) Estimate, Sales $37.000K
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 28, 2025 by benzinga